Ashley Hall
Chief Development Officer
Other
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2021 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Development Officer | $270,063 | $2,877,249 |
| 2020 | Esperion Therapeutics, Inc. (ESPR) | Former Chief Development Officer | $435,000 | $2,300,531 |
Earnings-call appearances
No earnings-call appearances recorded yet.